ArticleMolecular therapy : the journal of the American Society of Gene Therapy2011

RNAi-based therapeutics targeting survivin and PLK1 for treatment of bladder cancer.

Shaguna Seth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.